This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Rousselot B.v. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Praneeth Reddy Kuninty: Innovator in Post Intensive Care Treatment
Introduction
Praneeth Reddy Kuninty is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of healthcare, particularly in the treatment and prevention of post intensive care syndrome (PICS). His innovative approach focuses on the use of collagen hydrolysate, which has shown promise in improving recovery for patients after an intensive care unit (ICU) stay.
Latest Patents
Praneeth Reddy Kuninty holds a patent for his invention titled "Collagen hydrolysate for use in prevention and/or treatment of post intensive care syndrome (PICS)." This patent highlights the use of collagen hydrolysate as a supplement that can be administered during and after ICU stays. The invention aims to enhance recovery and prevent the onset of PICS, which can significantly affect patients' quality of life. The safety of collagen hydrolysate makes it a viable option for long-term preventive measures.
Career Highlights
Praneeth is currently employed at Rousselot B.V., where he continues to develop innovative solutions in the healthcare sector. His work is characterized by a commitment to improving patient outcomes and advancing medical treatments. With a focus on research and development, he has established himself as a key figure in his field.
Collaborations
Praneeth collaborates with talented professionals, including Elien Monique Gevaert and Janne Prawitt. These partnerships enhance the research and development process, allowing for a multidisciplinary approach to innovation in healthcare.
Conclusion
Praneeth Reddy Kuninty is a pioneering inventor whose work in collagen hydrolysate has the potential to transform post intensive care treatment. His dedication to improving patient recovery and quality of life is commendable. Through his innovative contributions, he continues to make a significant impact in the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile